- 関
- IL4 receptor、interleukin-4 receptor
WordNet
- the 9th letter of the Roman alphabet (同)i
- a cellular structure that is postulated to exist in order to mediate between a chemical agent that acts on nervous tissue and the physiological response
PrepTutorEJDIC
- 『私は』私が
- iodineの化学記号
- =sense organ / 受信装置
- Illinois
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2018/08/27 18:29:31」(JST)
[Wiki en表示]
IL4R |
---|
|
Available structures |
---|
PDB | Ortholog search: PDBe RCSB |
---|
List of PDB id codes |
---|
1IAR, 1IRS, 3BPL, 3BPN, 3BPO, 5E4E |
|
|
Identifiers |
---|
Aliases | IL4R, CD124, IL-4RA, IL4RA, Interleukin-4 receptor, interleukin 4 receptor |
---|
External IDs | MGI: 105367 HomoloGene: 7784 GeneCards: IL4R |
---|
Gene location (Human) |
---|
| Chr. | Chromosome 16 (human)[1] |
---|
| Band | 16p12.1 | Start | 27,313,668 bp[1] |
---|
End | 27,364,778 bp[1] |
---|
|
Gene location (Mouse) |
---|
| Chr. | Chromosome 7 (mouse)[2] |
---|
| Band | 7 F3|7 68.94 cM | Start | 125,552,120 bp[2] |
---|
End | 125,579,474 bp[2] |
---|
|
RNA expression pattern |
---|
| More reference expression data |
|
Gene ontology |
---|
Molecular function | • signal transducer activity, downstream of receptor • protein binding • cytokine receptor activity • interleukin-4 receptor activity
|
---|
Cellular component | • integral component of membrane • membrane • receptor complex • integral component of plasma membrane • extracellular region • extracellular space • plasma membrane
|
---|
Biological process | • immune system process • positive regulation of chemokine secretion • positive regulation of immunoglobulin production • positive regulation of macrophage activation • positive regulation of mast cell degranulation • response to estrogen • production of molecular mediator involved in inflammatory response • positive regulation of myoblast fusion • negative regulation of T-helper 1 cell differentiation • regulation of cell proliferation • immunoglobulin mediated immune response • immune response • positive regulation of T-helper 2 cell differentiation • ovulation • signal transduction • defense response to protozoan • interleukin-4-mediated signaling pathway • response to odorant • cytokine-mediated signaling pathway
|
---|
Sources:Amigo / QuickGO |
|
Orthologs |
---|
Species | Human | Mouse |
---|
Entrez | | |
---|
Ensembl | | |
---|
UniProt | | |
---|
RefSeq (mRNA) | |
---|
NM_000418 NM_001008699 NM_001257406 NM_001257407 NM_001257997 |
| |
---|
RefSeq (protein) | |
---|
NP_000409 NP_001244335 NP_001244336 NP_001244926 |
| |
---|
Location (UCSC) | Chr 16: 27.31 – 27.36 Mb | Chr 7: 125.55 – 125.58 Mb |
---|
PubMed search | [3] | [4] |
---|
Wikidata |
View/Edit Human | View/Edit Mouse |
|
Interleukin-4 receptor alpha chain, N-terminal |
---|
interleukin-4 / receptor alpha chain complex |
Identifiers |
---|
Symbol |
IL4Ra_N |
---|
Pfam |
PF09238 |
---|
InterPro |
IPR015319 |
---|
SCOP |
1iar |
---|
SUPERFAMILY |
1iar |
---|
Available protein structures: |
---|
Pfam |
structures |
---|
PDB |
RCSB PDB; PDBe; PDBj |
---|
PDBsum |
structure summary |
---|
|
The interleukin 4 receptor is a type I cytokine receptor. IL4R is its human gene.
Function
This gene encodes the alpha chain of the interleukin-4 receptor, a type I transmembrane protein that can bind interleukin 4 and interleukin 13 to regulate IgE antibody production in B cells. Among T cells, the encoded protein also can bind interleukin 4 to promote differentiation of Th2 cells. A soluble form of the encoded protein can be produced by an alternate splice variant or by proteolysis of the membrane-bound protein, and this soluble form can inhibit IL4-mediated cell proliferation and IL5 upregulation by T-cells. Allelic variations in this gene have been associated with atopy, a condition that can manifest itself as allergic rhinitis, sinusitis, asthma, or eczema. Two transcript variants encoding different isoforms, a membrane-bound and a soluble form, have been found for this gene.[5] Interactions of IL-4 with TNFα promote structural changes to vascular endothelial cells, thus playing an important role in tissue inflammation.[6]
The binding of IL-4 or IL-13 to the IL-4 receptor on the surface of macrophages results in the alternative activation of those macrophages. Alternatively activated macrophages (AAMΦ) downregulate inflammatory mediators such as IFNγ during immune responses, particularly with regards to helminth infections.[7]
Interactions
Interleukin-4 receptor has been shown to interact with SHC1.[8][9]
Structure
The N-terminal (extracellular) portion of interleukin-4 receptor is related in overall topology to fibronectin type III modules and folds into a sandwich comprising seven antiparallel beta sheets arranged in a three-strand and a four-strand beta-pleated sheet. They are required for binding of interleukin-4 to the receptor alpha chain, which is a crucial event for the generation of a Th2-dominated early immune response.[10]
See also
- Macrophage-activating factor
- Macrophage polarization
- Cluster of differentiation
- Fibronectin type III domain
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000077238 - Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000030748 - Ensembl, May 2017
- ^ "Human PubMed Reference:".
- ^ "Mouse PubMed Reference:".
- ^ "Entrez Gene: IL4R interleukin 4 receptor".
- ^ Thornhill, MH; Wellicome, SM; Mahiouz, DL; Lanchbury, JSS; Kyanaung, U; Haskard, DO (Jan 1991). "Tumor-necrosis-factor combines with IL-4 or IFN-gamma to selectively enhance endothelial-cell adhesiveness for T-cells-the contribution of vascular cell-adhesion molecule-1-dependent and molecule-1-independent binding mechanisms". Journal of Immunology. 146 (2): 592–598. PMID 1702807.
- ^ Tundup S, Srivastava L, Harn DA (April 2012). "Polarization of host immune responses by helminth-expressed glycans". Ann. N. Y. Acad. Sci. 1253: E1–E13. doi:10.1111/j.1749-6632.2012.06618.x. PMID 22974465.
- ^ Ikizawa K, Yanagihara Y (February 2000). "Possible involvement of Shc in IL-4-induced germline epsilon transcription in a human B cell line". Biochem. Biophys. Res. Commun. 268 (1): 54–9. doi:10.1006/bbrc.2000.2080. PMID 10652211.
- ^ Kashiwada M, Giallourakis CC, Pan PY, Rothman PB (December 2001). "Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation". J. Immunol. 167 (11): 6382–7. doi:10.4049/jimmunol.167.11.6382. PMID 11714803.
- ^ Hage T, Sebald W, Reinemer P (April 1999). "Crystal structure of the interleukin-4/receptor alpha chain complex reveals a mosaic binding interface". Cell. 97 (2): 271–81. doi:10.1016/S0092-8674(00)80736-9. PMID 10219247.
Further reading
- Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE (1999). "The IL-4 receptor: signaling mechanisms and biologic functions". Annu. Rev. Immunol. 17 (1): 701–38. doi:10.1146/annurev.immunol.17.1.701. PMID 10358772.
- Jiang H, Harris MB, Rothman P (2000). "IL-4/IL-13 signaling beyond JAK/STAT". J. Allergy Clin. Immunol. 105 (6 Pt 1): 1063–70. doi:10.1067/mai.2000.107604. PMID 10856136.
External links
- CD124+Antigen at the US National Library of Medicine Medical Subject Headings (MeSH)
PDB gallery |
---|
1iar: INTERLEUKIN-4 / RECEPTOR ALPHA CHAIN COMPLEX |
Cytokine receptors |
---|
Chemokine receptor (GPCRs) | CC |
- CCR1 / CCRL1
- CCR2
- CCRL2
- CCR3
- CCR4
- CCR5
- CCR6
- CCR7
- CCR8
- CCR9
- CCR10
|
---|
CXC |
- IL-8
- CXCR3
- CXCR4
- CXCR5
- CXCR6
- CXCR7
|
---|
Other | |
---|
|
---|
TNF receptor | 1-10 |
- TNFR1 (TNFRSF1A)
- TNFR2 (TNFRSF1B)
- LTBR (TNFRSF3)
- CD134 (TNFRSF4)
- CD40 (TNFRSF5)
- Fas receptor (TNFRSF6)
- DcR3 (TNFRSF6B)
- CD27 (TNFRSF7)
- CD30 (TNFRSF8)
- CD137 (TNFRSF9)
|
---|
11-20 |
- DR4 (TNFRSF10A)
- DR5 (TNFRSF10B)
- DcR1 (TNFRSF10C)
- DcR2 (TNFRSF10D)
- RANK (TNFRSF11A)
- Osteoprotegerin (TNFRSF11B)
- TweakR (TNFRSF12A)
- TACI (TNFRSF13B)
- BAFFR (TNFRSF13C)
- HVEM (TNFRSF14)
- NGFR (TNFRSF16)
- BCMA (TNFRSF17)
- GITR (TNFRSF18)
- TAJ/TROY (TNFRSF19)
|
---|
21-27 |
- DR6 (TNFRSF21)
- DR3 (TNFRSF25)
- EDA2R (TNFRSF27)
|
---|
|
---|
JAK-STAT | Type I | γ-chain |
- Interleukin receptors
- IL2R / IL2RA/IL2RB / IL15R
- IL4R / IL13R / IL13RA1 / IL13RA2
- IL7R / IL7RA
- IL9R
- IL21R
|
---|
β-chain |
- Interleukin receptors
- IL3R / IL3RA
- IL5R / IL5RA
- GM-CSF
|
---|
gp130 |
- Interleukin receptors
- IL6RA
- 11/IL11RA
- 27/IL27RA
- OSMR
- LIFR
- CNTFR
|
---|
IL12RB1 |
- Interleukin receptors
- IL12R/IL12RB1/IL12RB2
- IL23R23
|
---|
Other |
- hormone receptor: GH
- prolactin
|
---|
|
---|
Type II |
- Interleukin receptors
- IL10R / IL10RA / IL10RB / IL22R / IL22RA1 / IL22RA2
- IL20R / IL20RA / IL20RB
- IL28R
- Interferon receptors
- -α/β / IFNAR1/IFNAR2
- -γ/IFNGR1 / IFNGR2
|
---|
|
---|
Ig superfamily |
- CSF1
- KIT
- IL1
- IL18R / IL18R1
|
---|
IL 17 family |
- IL17
- IL17RA
- IL17RB
- IL17RC
- IL17RD
- IL17RE
|
---|
S/T | |
---|
Interleukin receptor modulators |
---|
IL-1 |
- Agonists: Interleukin 1 (α, β)
- Mobenakin
- Pifonakin
- Antagonists: AF-12198
- Anakinra
- IL-1RA
- Isunakinra
- Antibodies: Canakinumab
- Gevokizumab
- Lutikizumab
- Decoy receptors: Rilonacept (IL-1 Trap)
|
---|
IL-2 |
- Agonists: Adargileukin alfa
- Aldesleukin
- Celmoleukin
- Denileukin diftitox
- Interleukin 2
- Pegaldesleukin
- Teceleukin
- Tucotuzumab celmoleukin
- Antibodies: Basiliximab
- Daclizumab (dacliximab)
- Inolimomab
|
---|
IL-3 |
- Agonists: Daniplestim
- Interleukin 3
- Leridistim
- Milodistim
- Muplestim
- Promegapoietin
|
---|
IL-4 |
- Agonists: Binetrakin
- Interleukin 4
- Interleukin 13
- Antibodies: Dupilumab
- Pascolizumab
|
---|
IL-5 |
- Antibodies: Benralizumab
- Mepolizumab
- Reslizumab
- Antisense oligonucleotides: TPI ASM8
|
---|
IL-6 |
- Agonists: Atexakin alfa
- Interleukin 6
- Antibodies: ARGX-109
- Clazakizumab
- Elsilimomab
- mAb 1339
- Olokizumab
- Sarilumab
- Siltuximab
- Sirukumab
- Tocilizumab
|
---|
IL-7 | |
---|
IL-8 |
- See CXCR1 (IL-8Rα) and CXCR2 (IL-8Rβ) here instead.
|
---|
IL-9 | |
---|
IL-10 |
- Agonists: Ilodecakin
- Interleukin 10 (CSIF)
|
---|
IL-11 |
- Agonists: Interleukin 11 (AGIF)
- Oprelvekin
|
---|
IL-12 |
- Agonists: Edodekin alfa
- Interleukin 12
- Antibodies: Briakinumab
- Ustekinumab
|
---|
IL-13 |
- Agonists: Binetrakin
- Cintredekin besudotox
- Interleukin 4
- Interleukin 13
- Antibodies: Anrukinzumab
- Lebrikizumab
- Tralokinumab
|
---|
IL-15 |
- Agonists: ALT-803
- Interleukin 15
|
---|
IL-17 |
- Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F)
- Antibodies: Brodalumab
- Ixekizumab
- Perakizumab
- Remtolumab
- Secukinumab
- Vunakizumab
|
---|
IL-18 |
- Agonists: Iboctadekin
- Interleukin 18
- Interleukin 37
- Tadekinig
|
---|
IL-20 |
- Agonists: Interleukin 19
- Interleukin 20
- Interleukin 24
- Antibodies: Fletikumab (against IL-20)
|
---|
IL-21 |
- Agonists: Denenicokin
- Interleukin 21
- Antibodies: NNC0114-0005
- NNC0114-0006
|
---|
IL-22 |
- Antibodies: Fezakinumab (against IL-22)
|
---|
IL-23 |
- Agonists: Interleukin 23 (SGRF)
- Antibodies: Brazikumab
- Briakinumab
- Guselkumab
- Tildrakizumab
- Ustekinumab
|
---|
IL-27 |
- Agonists: Interleukin 27 (interleukin 30)
|
---|
IL-28 |
- Agonists: Interferon λ4 (IFN-λ4)
- Interleukin 28 (A (IFN-λ2), B (IFN-λ3))
- Interleukin-29 (IFN-λ1)
|
---|
IL-31 | |
---|
IL1RL1 | |
---|
IL1RL2 |
- Agonists: Interleukin 36 (α, β, γ)
- Interleukin 38
|
---|
Others | JAK | |
---|
Others |
- Interleukin 14 (taxilin alpha, HMW-BCGF)
- Interleukin 16 (signals through CD4)
- Interleukin 24 (signals through IL-22Rα1/IL-20Rβ heterodimer)
- Interleukin 26 (signals through IL-20Rα/IL-10Rβ heterodimer)
- Interleukin 32
- Interleukin 34 (signals through M-CSFR/CSF1R)
- Interleukin 35
- Unsorted: Efavaleukin alfa
- Efineptakin alfa
|
---|
|
---|
- See also
- Receptor/signaling modulators
- Signaling peptide/protein receptor modulators
- Cytokine receptor modulators
|
This article incorporates text from the public domain Pfam and InterPro IPR015319
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Enteric nematodes and the path to up-regulation of type 2 cytokines IL-4 and IL-13.
- Shea-Donohue T1, Sun R2, Bohl JA3, McLean LP3, Zhao A4.
- Cytokine.Cytokine.2015 Sep;75(1):62-7. doi: 10.1016/j.cyto.2015.06.007. Epub 2015 Jul 15.
- Protective immunity against enteric parasitic nematodes is dependent on IL-4, IL-13 activation of their exclusive transcription factor STAT6. The precise pathways by which enteric parasitic nematodes are recognized by the host is unclear, but elimination of this important interaction in developed na
- PMID 26188364
- Commentary: IL-4 and IL-13 receptors and signaling.
- McCormick SM1, Heller NM2.
- Cytokine.Cytokine.2015 Sep;75(1):38-50. doi: 10.1016/j.cyto.2015.05.023. Epub 2015 Jul 14.
- Interleukin (IL)-4 and IL-13 were discovered approximately 30years ago and were immediately linked to allergy and atopic diseases. Since then, new roles for IL-4 and IL-13 and their receptors in normal gestation, fetal development and neurological function and in the pathogenesis of cancer and fibro
- PMID 26187331
- Targeting of IL-4 and IL-13 receptors for cancer therapy.
- Suzuki A1, Leland P2, Joshi BH3, Puri RK4.
- Cytokine.Cytokine.2015 Sep;75(1):79-88. doi: 10.1016/j.cyto.2015.05.026. Epub 2015 Jun 15.
- The Th2 cytokines, interleukin (IL)-4 and -13, are structurally and functionally related. They regulate immune responses and the immune microenvironment, not only under normal physiological conditions, but also in cancer. Both cytokines bind to their high-affinity receptors and form various configur
- PMID 26088753
Japanese Journal
- Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling.
- Nakajima Saeko,Igyártó Botond Z,Honda Tetsuya,Egawa Gyohei,Otsuka Atsushi,Hara-Chikuma Mariko,Watanabe Norihiko,Ziegler Steven F,Tomura Michio,Inaba Kayo,Miyachi Yoshiki,Kaplan Daniel H,Kabashima Kenji
- The Journal of allergy and clinical immunology 129(4), 1048-1055.e6, 2012-04
- … Methods: By using Langerin-diphtheria toxin receptor knock-in mice and human Langerin-diphtheria toxin A transgenic mice, we prepared mice deficient in LCs. … We also prepared mice deficient in TSLP receptors in LCs by using TSLP receptor–deficient mice with bone marrow chimeric technique. …
- NAID 120004025593
- Association of mast cell-derived VEGF and proteases in dengue shock syndrome
- Furuta Takahisa,Murao Lyre Anni,Lan Nguyen Thi Phuong,Huy Nguyen Tien,Huong Vu Thi Que,Thuy Tran Thi,Tham Vo Dinh,Nga Cao Thi Phi,Ha Tran Thi Ngoc,Ohmoto Yasukazu,Kikuchi Mihoko,Morita Kouichi,Yasunami Michio,Hirayama Kenji,Watanabe Naohiro
- PLoS Neglected Tropical Diseases 6(2), e1505, 2012-02-21
- … To clarify the role of mast cells in the development of clinical Dengue fever, we compared the plasma levels of several mast cell-derived mediators (vascular endothelial cell growth factor [VEGF], soluble VEGF receptors [sVEGFRs], tryptase, and chymase) and -related cytokines (IL-4, -9, and -17) between patients with differing severity of Dengue fever and healthy controls. …
- NAID 120004442177
Related Links
- "Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation". J. Immunol. (United States) 167 (11): 6382–7. ISSN 0022-1767. PMID 11714803.
- The IL-4 receptor: signaling mechanisms and biologic functions. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD ...
★リンクテーブル★
[★]
- 英
- interleukin-4 receptor、IL-4 receptor
- 関
- インターロイキン4レセプター、IL-4受容体、IL-4レセプター
[★]
- 英
- interleukin-4 receptor、IL-4 receptor
- 関
- インターロイキン4受容体、IL-4受容体、IL-4レセプター
[★]
- 英
- IL-4 receptor
- 関
- インターロイキン4受容体、インターロイキン4レセプター、IL-4レセプター
[★]
- 英
- IL-4 receptor
- 関
- インターロイキン4受容体、インターロイキン4レセプター、IL-4受容体
[★]
- 関
- IL-4 receptor、IL4 receptor
[★]
[★]